ECMOHO Limited, an investment holding company, operates as an integrated solution provider in the non-medical health and wellness market. The company offers health supplements and food, mother and child care products, personal care products, and household healthcare equipment and cleaning products. It also operates an online e-commerce platform. The company is also involved in the provision of bonded area warehousing; online store operating services; and promotion and marketing services to its brand partners and other brand customers. It serves consumers and retailers. The company was founded in 2011 and is headquartered in Shanghai, the People's Republic of China.
IPO Year: 2019
Exchange: NASDAQ
Website: ecmoho.com
SC 13G/A - ECMOHO Ltd (0001763197) (Subject)
SC 13G/A - ECMOHO Ltd (0001763197) (Subject)
SC 13G/A - ECMOHO Ltd (0001763197) (Subject)
SHANGHAI, China, Dec. 06, 2021 (GLOBE NEWSWIRE) -- ECMOHO Limited (NASDAQ:MOHO) ("ECMOHO" or the "Company"), an integrated solutions provider in the health and wellness market in China, today announced a change in its board of directors (the "Board"). Mr. Greg Ye tendered to the Board his resignation as an independent director of the Board, the chair and a member of the audit committee of the Board and a member of the Nominating and Corporate Governance Committee of the Board for personal reasons, effective from December 1, 2021. Mr. Greg Ye's resignation did not result from any disagreement with the Company on any matter relating to the Company's operations, policies or practice. The Bo
SHANGHAI, China, March 17, 2022 (GLOBE NEWSWIRE) -- ECMOHO Limited (NASDAQ:MOHO) ("ECMOHO" or the "Company"), an integrated solutions provider in the health and wellness market in China, today announced that on March 16, 2022, the Listing Qualifications department of the Nasdaq Stock Market LLC ("Nasdaq") approved the Company's request to transfer the listing of the Company's American Depositary Shares (the "ADSs") from the Nasdaq Global Market to the Nasdaq Capital Market. The transfer is expected to take effect at the opening of business on March 17, 2022. The transfer of the Company's listing to the Nasdaq Capital Market is not expected to have any impact on trading in the Company's ADS
SHANGHAI, China, Feb. 15, 2022 (GLOBE NEWSWIRE) -- ECMOHO Limited (NASDAQ:MOHO) ("ECMOHO" or the "Company"), an integrated solutions provider in the health and wellness market in China, announced today that it will increase digital marketing efforts to achieve continuous positive marketing outcomes and profits. ECMOHO has partnered with B2C and B2B companies across industries and sectors to build brands, grow market share and increase loyalty and customer value with the right digital capabilities. ECMOHO has fully participated in Douyin to gain attention of younger audience. Through short video and live broadcasting, ECMOHO is benefiting from their strong fan base for disseminating heal
SHANGHAI, China, Dec. 06, 2021 (GLOBE NEWSWIRE) -- ECMOHO Limited (NASDAQ:MOHO) ("ECMOHO" or the "Company"), an integrated solutions provider in the health and wellness market in China, today announced a change in its board of directors (the "Board"). Mr. Greg Ye tendered to the Board his resignation as an independent director of the Board, the chair and a member of the audit committee of the Board and a member of the Nominating and Corporate Governance Committee of the Board for personal reasons, effective from December 1, 2021. Mr. Greg Ye's resignation did not result from any disagreement with the Company on any matter relating to the Company's operations, policies or practice. The Bo
SHANGHAI, China, Nov. 30, 2021 (GLOBE NEWSWIRE) -- ECMOHO Limited (NASDAQ:MOHO) ("ECMOHO", "we" or the "Company"), an integrated solutions provider in the health and wellness market in China, today announced its unaudited financial results for the third quarter ended September 30, 2021. Third Quarter 2021 Operational Highlights Number of brands offered by the Company increased to 41 as of September 30, 2021 from 39 as of June 30, 2021.Number of brand partners offered by the Company increased to 30 as of September 30, 2021 from 28 as of June 30, 2021.The cumulative number of partnered healthcare experts and KOLs grew from 1,216 as of September 30, 2020 to 1,591 as of September 30, 2021.
SHANGHAI, China, Oct. 21, 2021 (GLOBE NEWSWIRE) -- ECMOHO Limited (NASDAQ:MOHO) ("ECMOHO" or the "Company"), a leading integrated solutions provider in the health and wellness market in China, announced today that it has reached strategic cooperation agreement with the renowned U.S. vision care brand Bausch + Lomb to promote and sell its products and services on the Chinese e-commerce website Pinduoduo. Through the partnership, ECMOHO provide consumer and Chinese family with high-quality eye care products and family health solution to satisfy the rising demand for eye health. Bausch + Lomb has been a leading vision care company for more than 160 years, and is a global innovation leader wh
SHANGHAI, China, Sept. 21, 2021 (GLOBE NEWSWIRE) -- ECMOHO Limited (NASDAQ:MOHO) ("ECMOHO", "we" or the "Company"), an integrated solutions provider in the health and wellness market in China, today announced that it received a notification letter dated September 16, 2021 (the "Deficiency Letter") from the Listing Qualifications Department of The Nasdaq Stock Market Inc. (the "Nasdaq"), indicating that the Company is no longer in compliance with the minimum bid price requirement set forth in Rule 5450(a)(1) of the Nasdaq Listing Rules as the Company's closing bid price per American depositary share ("ADS"), each representing four Class A ordinary shares, par value US$0.00001 per share, of
SHANGHAI, China, Aug. 31, 2021 (GLOBE NEWSWIRE) -- ECMOHO Limited (NASDAQ:MOHO) ("ECMOHO", "we" or the "Company"), a leading integrated solutions provider in the health and wellness market in China, today announced its unaudited financial results for the second quarter ended June 30, 2021. Second Quarter 2021 Operational Highlights The cumulative number of partnered healthcare experts and KOLs grew from 1,114 as of June 30, 2020 to 1,542 as of June 30, 2021. The number of cumulative paying consumers1 was 12.1 million as of June 30, 2021 as compared to 10.1 million as of June 30, 2020.Repeat purchase rate2 reached 40.7% in the second quarter ended June 30, 2021 as compared to
NEW YORK, NY / ACCESSWIRE / August 5, 2021 / Aegis Capital Corp. acted as Sole Bookrunner on a $9 Million Follow-On Offering of American Depositary Shares for ECMOHO Limited (NASDAQ:MOHO).About ECMOHO LimitedECMOHO is an integrated solutions provider in the health and wellness market in China, which curates and sells global brands and quality products to Chinese health-conscious consumers. Leveraging its technology, network and expertise in marketing and distribution, ECMOHO connects families with advanced health supplements, nutrition and food items, personal care products, household healthcare equipment and other wellness products. Through over ten years of operation, ECMOHO has establishe
SHANGHAI, China, Aug. 05, 2021 (GLOBE NEWSWIRE) -- ECMOHO Limited (NASDAQ:MOHO) ("ECMOHO" or the "Company"), an integrated solutions provider in the health and wellness market in China, today announced the closing of an underwritten public offering of 10 million American Depositary Shares ("ADSs") at an offering price of US$0.90 per ADS for gross proceeds to the Company of US$9 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company, and assuming the underwriter does not exercise the option to purchase additional ADSs. Each ADS represents four Class A ordinary shares of the Company. The Company intends to use the net pro
SHANGHAI, China, Aug. 03, 2021 (GLOBE NEWSWIRE) -- ECMOHO Limited (NASDAQ:MOHO) ("ECMOHO" or the "Company"), an integrated solutions provider in the health and wellness market in China, today announced the pricing of an underwritten public offering of 10 million American Depositary Shares ("ADSs") at an offering price of US$0.90 per ADS for gross proceeds to the Company of US$9 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company, and assuming the underwriter does not exercise the option to purchase additional ADSs. Each ADS represents four Class A ordinary shares of the Company. The Company intends to use the net pro
SHANGHAI, China, Nov. 30, 2021 (GLOBE NEWSWIRE) -- ECMOHO Limited (NASDAQ:MOHO) ("ECMOHO", "we" or the "Company"), an integrated solutions provider in the health and wellness market in China, today announced its unaudited financial results for the third quarter ended September 30, 2021. Third Quarter 2021 Operational Highlights Number of brands offered by the Company increased to 41 as of September 30, 2021 from 39 as of June 30, 2021.Number of brand partners offered by the Company increased to 30 as of September 30, 2021 from 28 as of June 30, 2021.The cumulative number of partnered healthcare experts and KOLs grew from 1,216 as of September 30, 2020 to 1,591 as of September 30, 2021.
15F-12B - ECMOHO Ltd (0001763197) (Filer)
EFFECT - ECMOHO Ltd (0001763197) (Filer)
POS AM - ECMOHO Ltd (0001763197) (Filer)
S-8 POS - ECMOHO Ltd (0001763197) (Filer)
S-8 POS - ECMOHO Ltd (0001763197) (Filer)
6-K - ECMOHO Ltd (0001763197) (Filer)
25-NSE - ECMOHO Ltd (0001763197) (Subject)
6-K - ECMOHO Ltd (0001763197) (Filer)
20-F - ECMOHO Ltd (0001763197) (Filer)
NT 20-F - ECMOHO Ltd (0001763197) (Filer)
Gainers Spero Therapeutics, Inc. (NASDAQ:SPRO) shares jumped 167.7% to close at $2.20 on Thursday after the company announced it has entered into an exclusive license agreement with GSK for Spero's late-stage antibiotic asset, tebipenem HBr. Spero Therapeutics will receive $66 million upfront, with potential for future milestone payments, and tiered royalties. Avenue Therapeutics, Inc. (NASDAQ:ATXI) gained 105.9% to close at $0.44 after the company received meeting minutes from the FDA regarding a meeting conducted on August 9, 2022, for IV Tramadol. The company also announced the effectiveness of its 1-for-15 reverse split on Sept. 23. Panbela Therapeutics, Inc. (NASDAQ:PBLA) gained 46
Gainers Spero Therapeutics, Inc. (NASDAQ:SPRO) rose 150% to $2.0508 after the company announced it has entered into an exclusive license agreement with GSK for Spero's late-stage antibiotic asset, tebipenem HBr. Spero Therapeutics will receive $66 million upfront, with potential for future milestone payments, and tiered royalties. HeartBeam, Inc. (NASDAQ:BEAT) shares gained 34% to $2.12 after dropping 16% on Wednesday. Heartbeam recently announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of acute coronary syndrome and cardiac arrhythmia was issued by the USPTO. ShiftPixy, Inc. (NASDAQ:PIXY) shares jumped 32.4% to $18.09. ShiftPixy, on Wednesday, an
- Reuters
Gainers Spero Therapeutics, Inc. (NASDAQ:SPRO) rose 105.6% to $1.69 in pre-market trading. GSK and Spero Therapeutics announced exclusive license agreement for late-stage antibiotic asset, Tebipenem HBr. HeartBeam, Inc. (NASDAQ:BEAT) shares rose 27.8% to $2.02 in pre-market trading after dropping 16% on Wednesday. Heartbeam recently announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of acute coronary syndrome and cardiac arrhythmia was issued by the USPTO. American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) rose 20.1% to $0.2590 in pre-market trading. Taoping Inc. (NASDAQ:TAOP) rose 19.7% to $0.73 in pre-market trading. Taoping recently posted
Gainers Stabilis Solutions, Inc. (NASDAQ:SLNG) shares climbed 71.3% to close at $8.84 after the company announced it has received authorization from the U.S. Department of Energy to export domestically produced liquefied natural gas to all free trade and non-free trade countries. ECMOHO Limited (NASDAQ:MOHO) surged 50.3% to close at $0.1744. ECMOHO announced that it has received delisting notice from the Nasdaq. The company said it has elected to not appeal Nasdaq Listing Qualifications Department's determination. IDEX Biometrics ASA (NASDAQ:IDBA) gained 21.4% to close at $6.96. IDEX Biometrics and Sentry Enterprises will launch biometric smart card for digital authentication. Kaixin
U.S. stocks traded slightly higher toward the end of trading session on Wednesday following the announcement of interest rate decision by the Fed. The Dow traded up 0.06% to 30,725.62 while the NASDAQ rose 0.29% to 11,458.32. The S&P 500 also rose, gaining, 0.25% to 3,865.60. Also check this: Market Volatility Increases Sharply Ahead Of Fed's Rate Decision Leading and Lagging Sectors Consumer staples shares rose by 1.3% on Wednesday. Meanwhile, top gainers in the sector included General Mills, Inc. (NYSE:GIS), up 7% and Rite Aid Corporation (NYSE:RAD) up 5%. In trading on Wednesday, communication services shares fell by 0.1%. Top Headline The Federal Reserve raised interest
On Wednesday, 340 stocks hit new 52-week lows. Intriguing Points From Today's 52-Week Lows: Toyota Motor (NYSE:TM) was the largest firm on a market cap basis to set a new 52-week low. The smallest company in terms of market cap to set a new 52-week low was Virios Therapeutics (NASDAQ:VIRI). ECMOHO (NASDAQ:MOHO) made the largest move down on the session, with shares plummeting 64.13% to reach its 52-week low. AppLovin (NASDAQ:APP) shares bounced back the most, actually rising 0.0% after hiting a new 52-week low. The stocks that set new 52-week lows on Wednesday: Novartis (NYSE:NVS) shares set a new yearly low of $78.31 this morning. The stock was down 1.55% on the session. Ver
Gainers Stabilis Solutions, Inc. (NASDAQ:SLNG) shares jumped 108% to $10.73 after the company announced it has received authorization from the U.S. Department of Energy to export domestically produced liquefied natural gas to all free trade and non-free trade countries. Evaxion Biotech A/S (NASDAQ:EVAX) gained 47% to $3.0045 as the company reached an important milestone announcing that it had enrolled its first patient in the global phase 2b clinical trial of EVX-01, its personalized cancer therapy. AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC) gained 33% to $0.2001. ECMOHO Limited (NASDAQ:MOHO) jumped 31% to $0.1529. ECMOHO announced that it has received delisting notice from the